Virus-only testing may miss pneumonia-associated bacterial co-detections in 78% of virus-positive cases, while bacteria-only testing may miss viral co-detections in 88% of cases positive for pneumonia ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today highlighted its portfolio of molecular testing solutions ...

Routine ova and parasite (O&P) testing is likely to miss a Cyclospora infection, so physicians should be sure to request ...

Antibody testing shows whether you've had the COVID-19 virus in the past. It's not the same as testing to see whether you have the virus now.

Zion Market Research has published a new research report titled “Point-Of-Care Molecular Diagnostics Market By Product Type ...

A research team has developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that enables highly sensitive, ...

Measles resurgence poses serious risks for pregnant women and their unborn babies, highlighting the need for improved ...

Testing only for viruses such as influenza or COVID-19 when diagnosing respiratory infections can cause clinicians to miss a significant share of bacterial co-i ...

Industry-wide coverage policy expands reimbursement framework for donor-derived cell-free DNA testingSupports iMDx's commercial strategy in ...

Netherlands-based biotechnology company QIAGEN is expanding its footprint in the Philippines to address the country’s growing demand for advanced molecular diagnostics and laboratory automation as ...

Monsoon increases water-borne diseases like typhoid and hepatitis. Early diagnostic tests enable timely treatment, prevent ...

Three child deaths in Gujarat have put Chandipura virus in focus. Experts explain how it resembles Japanese encephalitis, why diagnosis matters and how labs guide outbreak control.